Dose-ranging study of pradefovir in patients with compensated hepatitis B
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Pradefovir (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bausch Health Companies; Valeant Pharmaceuticals International
- 03 Jul 2012 Extension study data integrated (NCT00230490).
- 21 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 26 Jan 2006 New trial record.